Activity Description
In this dynamic SYNChronicity 2026 opening plenary, thought leaders from across the healthcare ecosystem will explore how we move forward in synchronicity to ensure that progress in policy, AI, and innovation translates into meaningful gains in healthcare access and equity.
Speakers examine how federal and state policy decisions, such as the Affordable Care Act and Inflation Reduction Act, are influencing patient access and who benefits from new innovation; how AI is reshaping care delivery, diagnostics, and patient engagement; and how innovation can either close or widen longstanding disparities. Speakers also highlight strategies to align policy, technology, and community-centered approaches so that advances in care reach those who need them most. Join us for a forward-looking conversation on how to synchronize efforts across sectors — leveraging data, design, and policy — to build a healthcare future that is more accessible, inclusive, and equitable.
To receive CE credit for participation, you must pass the post-course knowledge check and complete the evaluation.
Target Audience
This activity is intended for healthcare professionals and support staff involved in the prevention, treatment, and coordination of HIV, HCV, STI, and LGBTQ health care, including physicians, nurses, pharmacists, physician associates, and behavioral health providers. It is also designed for public health professionals including state and local health department directors and staff, federal agency leads, and prevention program administrators. Additionally, this activity is relevant for allied health professionals, case managers, social workers, harm reductionists, health advocates, ASO and CBO leadership and staff, fiscal managers, students, researchers, and consumers with an interest in advancing equitable, person-centered care.
-
Media: Enduring Material
-
Start date: 06/01/2026
-
Expiration date: 03/31/2027
-
Time to Complete: 90 minutes
Educational Objectives
After completing this activity, the participant should be better able to:
-
Recognize how current federal healthcare policies are influencing healthcare access and equity.
-
Examine the opportunities and risks that AI and digital health innovations present to address health disparities.
-
Identify strategies to align policy, technology, and community-based approaches to ensure healthcare innovations are implemented equitably and sustainably
Accreditation, Credit, and Support
Participants can earn up to 1.5 credits/contact hours (CME, AAPA, ANCC, CPE, ASWB) for completion of this educational activity.
In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
HealthHIV designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Continuing Medical Education
Physician Associate Credit Designation Statement
HealthHIV
has been authorized by the American Academy of Physician Associates
(AAPA) to award AAPA Category 1 CME credit for activities planned in
accordance with AAPA CME Criteria. This activity is designated for 1.5
AAPA Category 1 CME credits. Approval is valid until 03/31/2027. PAs
should only claim credit commensurate with the extent of their
participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.5 contact hours.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for 1.5 contact hours (0.15 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned:
UAN JA4008396-0000-26-027-H99-P
Social Worker Continuing Education
As a
Jointly Accredited Organization, HealthHIV is approved to offer social
work continuing education by the Association of Social Work Boards
(ASWB) Approved Continuing Education (ACE) program. Organizations, not
individual courses are approved under this program. Regulatory boards
have the final authority on courses accepted for continuing education
credit. Social workers completing this course receive 1.5 general
continuing education credit.
Support Statement
This program has been supported by an independent educational grant from Merck Pharmaceuticals.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.
Faculty Disclosures
Elizabeth Kaplan, JD
Center For Health Law and Policy Innovation at Harvard Law School
Boston, MA
Disclosure: Center For Health Law and Policy Innovation receives funding from Gilead, ViiV Healthcare, and the Bristol Myers Squibb Foundation.
All relevant financial relationships have been mitigated in accordance with the standards of Joint Accreditation for Interprofessional Continuing Education™ and the ACCME Standards for Integrity and Independence in Accredited Continuing Education.Gary A. Puckrein, PhD
President and CEO of the National Minority Quality Forum
Washington, DC
Tori Cooper, Director of Strategic Outreach and Training
Human Rights Campaign
Washington, DC
Sam Tyner-Monroe, PhD, Director
Manatt, Phelps & Phillips, LLP
Washington, DC
Disclosure: Sam Tyner-Monroe has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Paul Luehr, Partner
Manatt, Phelps & Phillips, LLP
Washington, DC
Disclosure: Paul Luehr has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Katy Wendel, MHA, BSN, RN, ACRN, CENP
Vice President of Care Delivery Innovation
CAN Community Health
Sarasota, FL
Disclosure: Katy Wendel has the following relationships:
– Advisor, Consultant, or Independent Contractor for Gilead Sciences
– Recipient of research funding from Gilead Sciences
All relevant financial relationships have been mitigated in accordance with the standards of Joint Accreditation for Interprofessional Continuing Education™ and the ACCME Standards for Integrity and Independence in Accredited Continuing Education.Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (80% is required for ABS).
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
If you have any questions related to educational credits, including the type or amount of credit awarded, reporting of credits to certifying boards, or general accreditation-related inquiries, please contact the Accreditation Team at accreditation@healthhiv.org. A member of our team will be happy to assist you.
If you are experiencing issues accessing or downloading your certificate of completion, or if you have questions specifically about your individual certificate, please reach out directly to Beth at beth@healthhiv.org.
Activity Description
This plenary session will bring together nationally recognized leaders who exemplify true synchronicity across scientific discovery, clinical practice, policy, and real-world implementation. “Forward in SYNChronicity through Research and Care” highlights how aligning research, care delivery, advocacy, and public health strategy accelerates meaningful impact, advances innovation, and improves outcomes—particularly for communities most affected by HIV and related conditions. Featuring speakers who will provide critical updates on biomedical HIV prevention, vaccine preparedness, and key current research studies shaping the prevention landscape; the intersection of HIV care and drug user health, highlighting models that bridge treatment, harm reduction, and community-based support; lessons from long COVID research and chronic disease management that draw connections to HIV advocacy, research equity, and patient-led movements; and synchronizing policy and research with public health priorities and marginalized community needs.
Together, these leaders will illuminate how coordinated action across research, care, policy, and advocacy is not aspirational—it is essential. This session challenges us to move beyond silos and forward in deliberate synchronicity to drive equitable, durable progress in HIV and related health outcomes.
To receive CE credit for participation, you must pass the post-course knowledge check and complete the evaluation.
Target Audience
This activity is intended for healthcare professionals and support staff involved in the prevention, treatment, and coordination of HIV, HCV, STI, and LGBTQ health care, including physicians, nurses, pharmacists, physician associates, and behavioral health providers. It is also designed for public health professionals including state and local health department directors and staff, federal agency leads, and prevention program administrators. Additionally, this activity is relevant for allied health professionals, case managers, social workers, harm reductionists, health advocates, ASO and CBO leadership and staff, fiscal managers, students, researchers, and consumers with an interest in advancing equitable, person-centered care.
-
Media: Enduring Material
-
Start date: 06/01/2026
-
Expiration date: 03/31/2027
-
Time to Complete: 90 minutes
Educational Objectives
After completing this activity, the participant should be better able to:
-
Summarize current advances in biomedical HIV prevention, vaccine preparedness, and emerging clinical research.
-
Identify evidence-informed strategies that integrate HIV care, drug user health, long COVID, and chronic disease management to improve patient and population-level outcomes.
-
Describe approaches for aligning research, policy, and community priorities to advance equitable public health impact and inform programmatic or clinical decision-making
Accreditation, Credit, and Support
Participants can earn up to 1.5 credits/contact hours (CME, AAPA, ANCC, CPE, ASWB) for completion of this educational activity.
In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
HealthHIV designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Continuing Medical Education
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until March 31, 2027. PAs should only claim credit commensurate with the extent of their participation.Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.5 contact hours.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for 1.5 contact hours (0.15 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned:
JA4008396-0000-26-029-H99-P
Social Worker Continuing Education
As a
Jointly Accredited Organization, HealthHIV is approved to offer social
work continuing education by the Association of Social Work Boards
(ASWB) Approved Continuing Education (ACE) program. Organizations, not
individual courses are approved under this program. Regulatory boards
have the final authority on courses accepted for continuing education
credit. Social workers completing this course receive 1.5 general
continuing education credit.
Support Statement
This program has been supported by an independent educational grant from Merck Pharmaceuticals.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.
Faculty Disclosures
JD Davids, Strategist, HIV Activist, and Long Covid Advocate
Disclosure: JD Davids has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Judith Feinberg, MD
West Virginia University
Morgantown, WV
Gregorio Milett, MPH, Vice President and Director, Public Policy
amfAR
New York, NY
Disclosure: Gregorio Milett has disclosed the following relevant financial relationship with an ineligible company:
– Speaker or member of a speaker’s bureau for Gilead Sciences
Mitchel Warren, Executive Director
AVAC
New York, NY
Disclosure: Mitchel Warren has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Congressman Herb Conaway Jr., MD
New Jersey 3rd Congressional Distric
Washington, DC
Disclosure: Herb Conaway Jr has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (80% is required for ABS).
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
If you have any questions related to educational credits, including the type or amount of credit awarded, reporting of credits to certifying boards, or general accreditation-related inquiries, please contact the Accreditation Team at accreditation@healthhiv.org. A member of our team will be happy to assist you.
If you are experiencing issues accessing or downloading your certificate of completion, or if you have questions specifically about your individual certificate, please reach out directly to Beth at beth@healthhiv.org.
Activity Description
This closing plenary session examines how advocacy at different levels of the healthcare and prevention continuum can better move in concert together. Leading advocates discuss how policy change and service delivery can move together—from national strategy to community implementation. Drawing on experience from community organizing to global policy leadership, the session focuses on how coordinated advocacy turns uncertainty into durable systems change—and where misalignment continues to slow prevention and care delivery and long-term sustainability.
To receive CE credit for participation, you must pass the post-course knowledge check and complete the evaluation.
Target Audience
This activity is intended for healthcare professionals and support staff involved in the prevention, treatment, and coordination of HIV, HCV, STI, and LGBTQ health care, including physicians, nurses, pharmacists, physician associates, and behavioral health providers. It is also designed for public health professionals including state and local health department directors and staff, federal agency leads, and prevention program administrators. Additionally, this activity is relevant for allied health professionals, case managers, social workers, harm reductionists, health advocates, ASO and CBO leadership and staff, fiscal managers, students, researchers, and consumers with an interest in advancing equitable, person-centered care.
-
Media: Enduring Material
-
Start date: 06/01/2026
-
Expiration date: 03/31/2027
-
Time to Complete: 60 minutes
Educational Objectives
After completing this activity, the participant should be better able to:
-
Assess how coordinated advocacy across federal, state, local, and global levels shapes prevention and care delivery in today’s environments.
-
Explain how policy advocacy is carried into practice—and where gaps in that translation continue to constrain system sustainability, both long and short-term.
-
Engage effectively in federal, state, local, and global decision-making, knowing where prevention and care delivery decisions are made and how advocates and providers can shape outcomes before disruptions.
Accreditation, Credit, and Support
Participants can earn up to 1.0 credits/contact hours (CME, AAPA, ANCC, CPE, ASWB) for completion of this educational activity.
In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
HealthHIV designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Continuing Medical Education
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 03/312027. PAs should only claim credit commensurate with the extent of their participation.Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hours.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for 1.5 contact hours (0.15 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned:
JA4008396-0000-26-052-H02-P
Social Worker Continuing Education
As a
Jointly Accredited Organization, HealthHIV is approved to offer social
work continuing education by the Association of Social Work Boards
(ASWB) Approved Continuing Education (ACE) program. Organizations, not
individual courses are approved under this program. Regulatory boards
have the final authority on courses accepted for continuing education
credit. Social workers completing this course receive 1.0 general
continuing education credit.
Support Statement
This program has been supported by an independent educational grant from Merck Pharmaceuticals.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.
Faculty Disclosures
Lynn Albizo, JD
Chief Public Policy Officer
Immune Deficiency Foundation
Disclosure: Maxx Boykin has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Maxx Boykin
Campaign Manager
Save HIV Funding Campaign
Disclosure: Maxx Boykin has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Abdur-Rahim Briggs
Executive Board President - CEO
Project Briggs, Inc.
Disclosure: Abdur-Rahim Briggs has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Drew Gibson, MSW
Director of Advocacy
AIDS United
Disclosure: Drew Gibson has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Franklin Hood, MPS
Associate Director, Policy & Partnerships
Hepatitis B Foundation
Director,
Hep B United
Disclosure: Franklin Hood has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Amanda Jezek
Senior Vice President, Public Policy and Government Relations
Infectious Diseases Society of America
Disclosure: Amanda Jezek has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Jeremiah Johnson, MPH
Executive Director
PrEP4All
Disclosure: Jeremiah Johnson has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Stephanie Arnold Pang
Senior Director, Government Relations and Programs
NSCD
Disclosure: Stephanie Arnold Pang has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Shawn Tinsley
President/Executive Director, HIV Possible;
Chair-Woman SOS Broward Chapter
Disclosure: Shawn Tinsley has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Jose M. Zuniga, PhD, MPH
President & Chief Executive Officer
Fast-Track Health, IAPAC, and Fast-Track Cities Institute
Disclosure: Jose M. Zuniga has no relevant financial relationships with ineligible companies to disclose for this educational activity.Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (80% is required for ABS).
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
If you have any questions related to educational credits, including the type or amount of credit awarded, reporting of credits to certifying boards, or general accreditation-related inquiries, please contact the Accreditation Team at accreditation@healthhiv.org. A member of our team will be happy to assist you.
If you are experiencing issues accessing or downloading your certificate of completion, or if you have questions specifically about your individual certificate, please reach out directly to Beth at beth@healthhiv.org.